1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor : The AGITG ALT-GIST intergroup randomized phase II trial: Clinical Studies
Yip, Desmond ; Zalcberg, John ; Blay, Jean Yves ; Eriksson, Mikael LU
; Espinoza, David
; Price, Timothy
; Marreaud, Sandrine
; Italiano, Antoine
; Steeghs, Neeltje
and Boye, Kjetil
, et al.
(2025)
In British Journal of Cancer
132(10).
p.897-904
- Contribution to journal › Article
- 2022
-
Mark
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed : The Study Protocol for the Randomized Controlled NEEDS Trial
Nilsson, Magnus LU ; Olafsdottir, Halla ; Alexandersson von Döbeln, Gabriella ; Villegas, Fernanda ; Gagliardi, Giovanna ; Hellström, Mats ; Wang, Qiao Li LU
; Johansson, Hemming
; Gebski, Val
and Hedberg, Jakob
, et al.
(2022)
In Frontiers in Oncology
12.
- Contribution to journal › Article
- 2017
-
Mark
Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer : A phase III, randomised, multicentre trial (Ovaresist)
- Contribution to journal › Article